Condition
Metastatic Colorectal Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Metastatic Colorectal Adenocarcinoma clinical trials that are recruiting, at sites in 5 countries (most in United States (8), France (1), Spain (1)). By phase: Phase 1 (5), Phase 1/2 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 5Countries
Newest Metastatic Colorectal Adenocarcinoma clinical trials
All recruiting trials (9)
-
Dual-target CAR-NK therapy for advanced colorectal cancer
This trial tests an off-the-shelf CAR-NK cell treatment that targets two colorectal cancer markers in adults with unresectable or metastatic disease.
-
New oral medicine PF-08032562 for advanced or metastatic breast and colorectal cancer
This trial will try an oral medicine called PF-08032562, given alone or with other cancer drugs, in adults with advanced or metastatic breast or colorectal cancer.
-
Pidnarulex plus cemiplimab for refractory microsatellite-stable colorectal cancer.
This tests whether combining pidnarulex with cemiplimab is safe and can help people whose microsatellite-stable colorectal cancer has stopped responding to standard treatments.
-
Amplitude-modulated radiofrequency therapy plus fruquintinib for refractory metastatic colorectal cancer
This trial will test whether adding amplitude-modulated radiofrequency electromagnetic fields to the drug fruquintinib helps people with metastatic colorectal cancer that has not responded to standard treatments.
-
Combining CA-4948 with chemotherapy for metastatic colorectal cancer
This study is testing a new drug called CA-4948 combined with chemotherapy to see if it can safely help people with metastatic colorectal cancer.
-
Combining botensilimab, balstilimab, a fasting mimicking diet, and vitamin C for KRAS-mutant metastatic colorectal cancer
This study is testing if combining two new antibodies with a special diet and vitamin C can help people with KRAS-mutant metastatic colorectal cancer live longer and feel better.
-
Combining ZEN003694 with standard chemotherapy for advanced colorectal cancer
This study is testing if a new drug called ZEN003694 can safely improve the effects of standard chemotherapy for people with advanced colorectal cancer that hasn't responded to other treatments.
-
Combining total ablative therapy with standard treatment for limited metastatic colorectal cancer
This study is testing if adding a special type of radiation therapy and possible surgery to standard chemotherapy can help people with limited metastatic colorectal cancer live longer and stay healthier.
-
Combining trifluridine/tipiracil with talazoparib for advanced colorectal or gastroesophageal cancer
This study is testing a new combination of two cancer drugs to see if they can safely help people with advanced colorectal or gastroesophageal cancer.
Related topics
Quick answers
How many Metastatic Colorectal Adenocarcinoma clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (8 trials), France (1 trial), Spain (1 trial), China (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 5, Phase 1/2: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.